Time is running out to ensure your pharmaceutical company remains compliant with the FDA's annual reporting requirements! This year, Over-the-Counter (OTC) manufacturers face unique challenges due to recent changes in OTC monograph regulations. Act now to avoid possible FDA misbranding!

Avoid non-compliance – take immediate action to understand and address these new requirements. With critical year-end deadlines fast approaching for Establishment Registrations, Drug Product Listings and No-Change Certifications, the FDA will be inundated with submissions. Submit your filings well in advance to ensure timely processing and avoid potential delays. For those manufacturers that also market Cosmetic products, we will also summarize the year-end listing requirements.  

Watch a recording of an educational webinar on this topic, recorded on  December 4th, hosted by LexisNexis Reed Tech subject-matter experts. This is your opportunity to gain invaluable insights and ensure your company is fully prepared for the upcoming deadlines and OTC monograph changes.

Time is of the essence – watch now to gain insights that will assist in safeguarding your pharmaceutical business from non-compliance risks.